MN-002

N/A

Report date: 2022/08/19 15:33:30

Base Information

Drug NameMN-002
Drug Alias NameMN-002
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal fibrosisFibrosisMacular Degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicinova Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedicinova Inc
Inactive CompaniesN/A
Active IndicationsRenal fibrosisFibrosisMacular Degeneration +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A